Literature DB >> 1765643

A simple and improved method to generate human hybridomas.

T Kudo1, H Saeki, T Tachibana.   

Abstract

By improving our previous method for production of human hybridomas, we developed a simple and remarkably efficient method for production of human hybridomas. We reformed our previous method in the following three points: (1) we added irradiated (30 Gy) myeloma cells as feeder cells to culture of fusion cells; (2) ouabain concentration in the selective medium was reduced from 2 x 10(-6) M to 1 x 10(-6) M; (3) selective medium (GIT-HAT-OL) was added to the culture after overnight cultivation of fusion cells. Consequently, we obtained higher fusion frequency (1/700 vs. 1/5500) compared with our previous method. By our present method, only so small number of human B cells (EBV-LCL) is required, so that the time necessary to establish human hybridomas is reduced.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1765643     DOI: 10.1016/0022-1759(91)90317-9

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  3 in total

Review 1.  Strategies of targeting the extracellular domain of RON tyrosine kinase receptor for cancer therapy and drug delivery.

Authors:  Omid Zarei; Silvia Benvenuti; Fulya Ustun-Alkan; Maryam Hamzeh-Mivehroud; Siavoush Dastmalchi
Journal:  J Cancer Res Clin Oncol       Date:  2016-08-08       Impact factor: 4.553

Review 2.  Biological response modifiers in cancer.

Authors:  Purabi Reang; Madhur Gupta; Kamlesh Kohli
Journal:  MedGenMed       Date:  2006-11-14

3.  A novel human monoclonal antibody directed to a tumor-associated antigen.

Authors:  T Kudo; S Kobayashi; K Murakami; R Takano; M Nose; N Sato; H Saeki; S Saijyo; S Hiyamuta; A Kadota
Journal:  Jpn J Cancer Res       Date:  1993-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.